
Camille Keenan
Director · University of Washington School of Medicine
Credentials: · · · · · · ·
History
Research
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
Review · Frontiers in Immunology · 2021 · First of 3 authors · 156 citations
Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy
British Journal of Haematology · 2021 · 112 citations
Journal of Orthopaedic Research® · 2013 · 73 citations

6 papers

3 papers · 3 as a fellow

2 papers
- SU
2 papers

1 paper

1 paper

1 paper

1 paper






